State-of-the-art proteomics software routinely quantifies thousands of peptides per experiment with minimal need for manual validation or processing of data. For the emerging field of discovery lipidomics via liquid chromatography-tandem mass spectrometry (LC-MS/MS), comparably mature informatics tools do not exist. Here, we introduce LipiDex, a freely available software suite that unifies and automates all stages of lipid identification, reducing hands-on processing time from hours to minutes for even the most expansive datasets. LipiDex utilizes flexible in silico fragmentation templates and lipid-optimized MS/MS spectral matching routines to confidently identify and track hundreds of lipid species and unknown compounds from diverse sample matrices. Unique spectral and chromatographic peak purity algorithms accurately quantify co-isolation and co-elution of isobaric lipids, generating identifications that match the structural resolution afforded by the LC-MS/MS experiment. During final data filtering, ionization artifacts are removed to significantly reduce dataset redundancy. LipiDex interfaces with several LC-MS/MS software packages, enabling robust lipid identification to be readily incorporated into pre-existing data workflows.
INTRODUCTION
When coupled with chromatographic separation, the high resolution, mass accuracy, and speed of modern mass spectrometry (MS) systems render them the premier tool for unbiased analysis of diverse biomolecules (Cajka and Fiehn, 2016; Hebert et al., 2014; Patti et al., 2012) . Although less mature relative to other -omics technologies ( Figure S1 ), discovery lipidomic analysis by liquid chromatography-tandem MS (LC-MS/MS) is poised to make significant contributions to biomedical research. Already this technology has uncovered novel lipids that improve glucose tolerance in mice (Yore et al., 2014), mapped lipid remodeling during platelet activation (Slatter et al., 2016) , and revealed lipid dysregulation antecedent to islet autoimmunity in type 1 diabetes (Oresic et al., 2008) . However, on account of lipid structural heterogeneity, co-fragmentation of isobaric lipids, and chromatographic peak (feature) degeneracy, significant data analysis challenges remain (Cajka and Fiehn, 2014; Kuhl et al., 2012; Mahieu and Patti, 2017) .
Currently, numerous informatics approaches exist to address one or more of these challenges, including mzMine 2 (Pluskal et al., 2010) , LipidBlast (Kind et al., 2013) , LipidSearch (Taguchi and Ishikawa, 2010) , MS-Dial (Tsugawa et al., 2015) , LipidMatch (Koelmel et al., 2017) , and Lipid Data Analyzer 2 (Hartler et al., 2017) . Accurate lipid identification requires customizable in silico spectral libraries, lipid-specific MS/MS matching, accurate assignment of MS/MS identifications to chromatographic peaks, and multi-dimensional downstream data filtration (Tsugawa et al., 2017a) . To promote broad usability and acceptance, these elements should be vendor neutral and integrated in graphical user interface (GUI)-based software suites. At present, realizing this ideal workflow for global feature profiling often requires either significant manual validation or integration of multiple software packages. We developed LipiDex to automate and unite these crucial lipid identification steps into a single intuitive software package capable of efficiently processing expansive lipid datasets.
RESULTS

Lipid Identification and Quantitation Workflow
LipiDex comprises a set of lipid spectral library management and data-processing tools optimized for high-resolution MS analysis and linked together in an intuitive GUI ( Figure 1A ). Developed in Java (JRE v.1.8.0) , LipiDex runs efficiently on multiple operating systems, supports vendor-neutral and open-source MS file types, and accepts chromatographic feature tables from several commercial and open-source LC-MS/MS software packages. Here we describe LipiDex's major lipid identification algorithms and demonstrate their performance with multiple datasets. A detailed explanation of the algorithms is provided in STAR Methods, a feature comparison with other software packages is provided in Figure S2 , and the software suite and accompanying multimedia tutorials describing the use of LipiDex's major functions are freely available at http://www.ncqbcs.com/resources/software/.
To achieve confident lipid identification at the sum or molecular composition level (Liebisch et al., 2013) , LipiDex integrates precursor mass-to-charge (m/z), fragmentation spectra, chromatographic retention time, and chromatographic elution profile ( Figure 1B) . In silico lipid spectral libraries for MS/MS identification are first created by Library Generator, which utilizes a set of customizable lipid metadata tables and fragmentation rules to accurately model the m/z and relative intensity of diverse fragment types ( Figure S2 ) (Kind et al., 2014) . To facilitate utilization, LipiDex includes extensive pre-built spectral libraries based on numerous authentic reference standards, experimental identifications, and published databases (refer to Tables S1 and S2 for library composition) (Kind et al., 2014; Tsugawa et al., 2017b) . Next, Spectrum Searcher generates lipid spectral matches by searching experimental MS/MS spectra against these libraries using a two-step searching algorithm. Experimental MS/MS spectra are first assigned putative identifications via a modified dot-product score ( Figure 1C ) and are then deconvoluted to quantify lipid co-fragmentation ( Figure 1D ). Peak Finder links these MS/MS identifications with externally generated feature tables using a Gaussian peak model to accurately assign quantitative abundance values to unique lipid species ( Figure 1E ). Final result filtering, lipid grouping, and retention time filtering remove degenerate peaks and collapse redundant identifications ( Figure 1F ), automating the manual data validation normally required for robust large-scale discovery lipidomics.
Generating Confident Lipid Identifications
Although many powerful LC-MS/MS analysis packages identify chromatographic features from user-supplied or public spectral libraries, these packages are not specifically optimized for lipid data analysis. Accordingly, we present several in silico and experimental datasets for the optimization and validation of LipiDex's core functions. To generate candidate spectral matches, MS/MS spectra are searched against user-selected spectral libraries leveraging a lipid-optimized dot-product spectral similarity score and the intact precursor m/z as a search constraint. The dot-product score represents the scaled cosine of the angle between the in silico and experimental spectral vectors (Stein and Scott, 1994) and contains mass (n) and intensity (m) weighting factors, which can be modulated to tailor the equation to specific applications (Kim et al., 2012) . In Figure 2A , we demonstrate the systematic optimization of these terms using a structurally diverse set of 82 lipid reference standard spectra fragmented via higher-energy collisional dissociation (HCD) from the NIST Tandem Mass Spectral Library (National Institute (C) Identification of MS/MS spectra (gray circles and red spectrum) using in silico lipid databases and a modified dot-product scoring algorithm that ranks identifications according to spectral similarity to library entries (blue spectrum).
(D) Spectral deconvolution and relative quantitation (colored circles) of co-fragmented isobaric lipid species by sequential matching against and subtracting from the experimental spectra.
(E) Accurate association of MS/MS identifications to chromatographic features via Gaussian peak modeling (shaded color).
(F) Calculation of total peak purity for each chromatographic peak across all samples using the Gaussian peak profile to modify spectral purity measurements. (G) Final identification of each chromatographic peak using either the sum composition (i.e., PC 40:1) or molecular composition (i.e., PC 16:1_24:0) if the weighted peak purity rises above a user-supplied threshold.
of Standards and Technology, 2012) . The optimal weighting factor set (m: 1.2; n: 0.9) returns a median top match similarity score of 955, a median first and second match score difference of 887, and 82 correct identifications (Figure 2A ), and performs similarly well for collision-induced dissociation (CID) spectra ( Figure S5 ) and LC-MS/MS analysis of pure reference standards ( Figure S6 ). Importantly, this large difference between the first and second match scores greatly increases spectral match confidence in the absence of a false discovery rate (FDR) estimate as commonly used in spectral matching for discovery proteomics. Spectral similarity scoring's accuracy markedly improves upon addition of orthogonal identification filters (Kwiecien et al., 2015) , particularly for spectra containing multiple co-fragmented lipid regioisomers (Hartler et al., 2017; Koelmel et al., 2017) . Spectrum Searcher utilizes a unique spectral deconvolution algorithm to quantify the co-fragmentation of isobaric lipids ( Figure S6 ). In Figure 2B , we demonstrate spectral deconvolution for a complex experimental triacylglycerol (TG) spectrum where multiple TGs share common chain-identifying fragments. By sequentially subtracting select matched fragments, the deconvolution algorithm avoids assigning the full intensity of fragments shared by multiple isobaric precursors to each species, an inaccuracy inherent to methods that sum the intensity of all matched fragments (Hartler et al., 2017; Koelmel et al., 2017) . The accuracy of the algorithm is globally demonstrated using a set of pure isobaric phospho-, glycero-, and sphingolipid spectral pairs extracted from experimental LC-MS/MS data and mixed in silico at various ratios to simulate co-fragmentation ( Figure 2C ). The deconvolution algorithm accurately returns the correct mixing ratio for the vast majority of in silico pairs (average spectral purity error of 3.5). Note that the returned values represent a metric of spectral purity and are not used to modify the peak area values for associated features, rendering small inaccuracies in the purity value insignificant. Removing redundant features that arise from the same analyte (degenerate features) and data artifacts generated from the discovery LC-MS/MS lipidomic workflow is a critical step for robust downstream statistical analysis, which often requires significant manual data validation (Collins et al., 2016; Kuhl et al., 2012; Mahieu and Patti, 2017) . To minimize this laborious but essential step, LipiDex automatically detects and removes degenerate identified and unidentified features. In Figure 2D , we present the LC-MS/MS analysis and data filtration of complex lipid extracts of human Hap1 cells, human plasma, mouse liver, and yeast cells. After removal of features present in a blank injection by the peak picking software, each dataset contains thousands of features (8,276, 9,287, 8,494, and 4,921, respectively) . LipiDex automatically removes spurious feature detections, adducts, dimers, in-source fragments, and misidentified isotopes, resulting in an average feature reduction of 59%.
After removal of artifacts, LipiDex infers the minimum number of lipid identifications, which accurately explain all identified lipid features and their associated MS/MS identifications ( Figure S7 ) in a process roughly analogous to protein inference (Nesvizhskii and Aebersold, 2005) . Although these filters remove the vast majority of incorrect lipid identifications, false positives can remain. Lipid retention time represents a highly specific and orthogonal filter that can greatly improve identification confidence (Aicheler et al., 2015; Hartler et al., 2017; Tsugawa et al., 2015 Tsugawa et al., , 2017b . Many approaches predict lipid retention time by correlating chemical identifiers to experimentally measured retention times, which inherently requires a static chromatographic setup. LipiDex circumvents this problem by implementing an optional outlier detection algorithm to remove lipid identifications falling outside of the retention time cluster elution pattern of lipid reversed-phase analysis ( Figure S8 ). While these filters do not exhaustively remove degenerate features or false identifications in a sample, the tremendous reduction in candidate features significantly expedites data validation and makes LipiDex a flexible tool for discovery lipidomic analysis.
DISCUSSION
Highly scalable, automated, and robust lipid identification is readily achievable with LipiDex. LipiDex has already been used in multiple lipidomics studies to analyze a wide array of sample types (Lapointe et al., 2017; Reidenbach et al., 2018; Rhoads et al., 2018; Stefely et al., 2016; Veling et al., 2017; Velsko et al., 2017) . To extend this identification capability to new biological systems of interest and novel fragmentation techniques, LipiDex's extensive curated lipid databases are easily expanded using its intuitive fragmentation templates. Beyond library generation, the detailed fragmentation metadata provided for each predicted MS/MS fragment empowers accurate spectral matching and deconvolution. Unlike many general small-molecule data analysis packages, LipiDex dynamically modifies the structural resolution encoded within each lipid identification to match the experimental MS/MS data. Moreover, these and other unidentified features are extensively filtered to remove degenerate peaks, redundant lipid identifications, and spurious lipid features. In the absence of a method to calculate an FDR, LipiDex applies multi-dimensional filtering to increase lipid identification confidence. Recently published methods for small-molecule FDR estimation via target-decoy methods raise the tantalizing possibility of statistically rigorous lipid identification (Palmer et al., 2016; Scheubert et al., 2017) . We note that LipiDex's detailed fragmentation rule sets may prove valuable for automatically generating realistic and expandable decoy databases, a vital step for the rapid evolution of discovery lipidomic analysis into an essential systems biology tool.
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METHOD DETAILS Supported Lipidomic Workflows
LipiDex bases lipid identifications on accurate precursor m/z and matching of high or low resolution MS/MS spectra against theoretical in-silico libraries. These identifications are then extensively filtered to ensure datasets with minimal artefactual and redundant entries. Although the software was initially developed and benchmarked using RP-LC-MS/MS data collected on the Q-Exactive platform, it supports numerous common lipidomic workflows from diverse LC-MS/MS setups including acetate and formate mobile phase systems, reversed phase and HILIC separations, HCD and CID fragmentation spectra, and fast polarity switching and separate polarity data acquisition. Additionally, the flexible spectral library generation tools allow the software package to be readily expanded to cover novel lipid classes and fragmentation templates. Currently, LipiDex does not support data collected using data-independent acquisition (DIA), all ion fragmentation (AIF), or infusion-based methods. REAGENT Spectral Similarity Matching Candidate lipid identifications are assigned to experimental MS/MS spectra using a modified dot-product spectral similarity score. First, user-selected in-silico lipid spectra are extracted from generated .msp files and binned by precursor m/z for efficient retrieval prior to spectral matching. Experimental MS/MS spectra in the Mascot Generic Format (MGF) or mzXML format are then extracted and the fragment intensities normalized to 1000. All library spectra whose intact precursor m/z falls within a user-defined tolerance of the experimental MS/MS precursor m/z are then compared to the experimental MS/MS using the dot-product score. The following dot-produce equation is used to measure spectral similarity:
The optimized intensity (m = 1.2) and mass (n = 0.9) weighting factors give greater emphasis to higher m/z and intensity fragments which often identify individual fatty acid moieties of the lipid. To reduce the deleterious effect of co-fragmented lipid species on spectral scoring, the intensities of peaks present in the experimental spectrum but not in the library entry are reduced by 50% (Tsugawa et al., 2015) . For the reverse dot-product score, only peaks present in both experimental and library spectra (within the user-defined m/z tolerance) are considered for spectral similarity scoring. Peak Finder utilizes both the standard and reverse dot-product scores to filter out potential false identifications whose spectral similarity scores fall below a user-supplied threshold.
Spectral Deconvolution
Accurate quantification of co-fragmentation of isobaric lipids and total spectral purity follows the logic flow detailed in Figure S2 . For a given MS/MS spectrum, all spectral matches are ranked according to their dot-product score and added to the scan queue (SQ). Next, fragmentation template entry for each candidate lipid species is queried to find the fatty acid-identifying fragment type which is assigned the highest relative intensity. The experimental spectrum is then searched for fragments which correspond to this rule type. If all of the predicted highest intensity chain-identifying fragments are not found, the candidate identification is discarded. If all predicted highest intensity chain-identifying fragments are found, the relative intensity of matched fragments is corrected using any matching m/z values found in the correction list (CL). The corrected m/z values are then assigned the median intensity of the matched fatty acid-identifying fragments and added to the CL. Depending on the number of fatty acids for the identified lipid, either the median or maximum matched intensity is added to the intensity list (IL). This intensity value is used to quantify the relative abundance of the lipid in the MS/MS spectrum. This process is repeated until no candidate spectra remain. All intensities found in the IL are then scaled to the sum of all matched species' intensities.
Feature-MS/MS Association
LipiDex accepts chromatographic feature tables generated by Compound Discoverer (Thermo Fisher Scientific) or MZmine 2 (v. 2.30) (Pluskal et al., 2010) . To associate lipid spectral matches with their parent features, each feature is modeled using a Gaussian function generated from the feature metadata in the imported table. The following function is used for Gaussian modeling:
The parameter a is the apex height of the feature, b is the apex retention time, and FWHM is the full peak width at half of the maximum intensity. MS/MS identifications whose dot-product score is greater than a user-supplied threshold are then linked to chromatographic features if they stem from the same sample and if they share the same charge, precursor m/z (within user-supplied tolerance), and retention time. As MS/MS are not necessarily acquired at the feature apex, spectra are assigned to features if the retention time falls within a user-specified factor of the feature's peak width (FWHM). To accurately associate spectra for partially co-eluting isobaric peaks, each spectrum is assigned to the peak which has the highest Gaussian-modeled intensity at that retention time.
Weighted Peak Purity
To quantify co-elution of isobaric features, LipiDex combines the Gaussian feature profile and the deconvoluted spectral purity values to calculate a weighted purity value for the feature across all samples (feature group). All identified lipid spectral components generated from spectral deconvolution and assigned to a specific feature group are weighted according to their proximity to the peak apex using the Gaussian peak model. These weighted values are then used to calculate a weighted average for each component assigned to the feature group.
Spurious Peak Detection Filtering
When analyzing complex LC-MS data, feature detection software routinely identifies chromatographic peaks which cannot be reliably quantified across many samples. These features are often of low abundance, suffer from poor chromatographic resolution, or are artifacts of the specific peak detection routine (Mahieu et al., 2015) . To remove these features, LipiDex discards all feature groups which were not detected in at least a user-supplied number of LC-MS experiments from the dataset.
Degenerate Peak Filtering
Following assignment of MS/MS identifications to features, co-eluting feature groups are filtered to remove redundant adduct, multimers, misidentified isotopes, and in-source fragments. Feature groups are considered to co-elute if the apex retention time difference is less than half the average peak width (FWHM). In this way, small differences in apex retention time, which can arise from polarity-switching LC-MS/MS experiments, do not erroneously disqualify potential degenerate feature groups. Co-eluting peaks are considered adducts or dimers of the same parent compound if they satisfy the following equations within a user-defined m/z tolerance:
Here, m refers to the precursor m/z for feature groups 1 or 2 and a denotes the m/z of adducts x or y. All potential adduct combinations for the correct polarity are taken from a user-supplied list in Peak Finder. If two features are determined to stem from the same parent compound, the feature with the largest area is retained and the other discarded. If only one of the features is identified as a lipid from its MS/MS spectra, that feature is retained and the feature without an MS/MS spectral identification is discarded. A feature group is considered an in-source fragment if it's precursor m/z is found in the assigned MS/MS identification in-silico spectrum for any co-eluting feature group. Occasionally, LC-MS feature extraction tools will misidentify the M+1 isotope as the M0 isotope. LipiDex removes these errors by searching for co-eluting peaks whose m/z differs by the mass of a neutron within a user-defined mass tolerance.
Lipid Grouping
Lipid grouping refers to the collapsing of redundant lipid identifications and modulation of the structural resolution embedded in the lipid identification (sum vs. molecular composition) based on the assigned MS/MS identifications. In this way, the minimum set of lipid identifications which supports the observed features and MS/MS are reported. Common lipid grouping scenarios are outlined in Figure S2 . After lipid grouping, feature groups are identified with the sum composition (i.e. PC 34:1) when the MS/MS spectra support multiple isobaric identifications ( Figure S2C ) or contain significant co-fragmentation of isobaric lipids ( Figure S2E ). Lipids identifications are given the molecular composition (i.e. PC 16:0_18:1) if, after combining redundant adducts, the MS/MS spectra contain fattyacid identifying fragments ( Figures S2A and S2D ) with minimal co-fragmentation.
Retention Time Filtering
Lipid retention times (RT) for a specific lipid class roughly approximate a normal distribution in reversed-phase chromatographic separation. In LipiDex, lipid identifications are optionally filtered via retention time using an LC system-agnostic outlier detection. First, apex retention times for all identified feature groups are extracted and grouped together by lipid class. If there are at least four identifications for the specific lipid class, the median absolute RT deviation from the median (MAD) is calculated. MAD represents a more robust method for outlier detection than the standard deviation alone (Leys et al., 2013) . Any identification which falls outside of a user-defined multiple of this value (3.5 by default) is considered to be a spurious identification and removed. In cases where there are very few identified lipids from a given class or non-endogenous lipid internal standards are used, true identifications may fall outside the class retention time window. In these or other instances of erroneous outlier detection, the user can either toggle the retention time filtering off or find the removed lipid in the Unfiltered Peak List CSV file.
Hap1 Collection HAP1 cells were maintained in high glucose (25 mM) Iscove's Modified Dulbecco's Medium supplemented with 10% (v/v) fetal bovine serum and penicillin-streptomycin (IMDM, FBS, PS) in a humidified incubator (37 C, 5% CO 2 ). Cells were subcultured by trypsinization (0.05% Trypsin-EDTA). Two million HAP1 cells were plated into a 10 cm dish with IMDM, FBS, PS (37 C, 10 mL) and incubated (37 C, 5% CO 2 ) for 46 h (until the cultures were $50-60% confluent). The media was gently aspirated and replaced with glucose-free DMEM, FBS, PS with galactose (10 mM) and incubated (37 C, 5% CO 2 , 24 h). Immediately prior to cell harvest, the media was aspirated and the cells were gently washed with PBS ($2 mL, $20 C). The PBS wash was aspirated, PBS (700 mL, 4 C) was added, and the cells were harvested by scraping and transferring the resuspended cells into a 1.5 mL tube on ice. The cells were isolated by centrifugation (5000 g, 1 min, 4 C). The supernatant was aspirated, and the cell pellets were snap frozen in N 2 (l) and stored at -80 C.
Yeast Collection
An individual colony of yeast was used to inoculate a starter culture (3 mL pABA-,G, D) and incubated (30 C, 230 rpm, 10-15 h). Media (100 mL media at ambient temperature in a sterile 250 mL Erlenmeyer flask) was inoculated with 2.5x10 6 yeast cells and incubated (30 C, 230 rpm). Samples were harvested 25 h after inoculation. 1x10 8 yeast cells were harvested by centrifugation (3,000 g, 3 min, 4 C), the supernatant was removed, and the cell pellet was flash frozen in liquid nitrogen. Pellets were stored at À80 C prior to extraction.
Hap1 Cell, Yeast, and Mouse Liver Lipid Extraction Yeast cell pellets, mouse liver homogenates (100 mg), and HAP1 cell pellets were thawed on ice and each sample was mixed with glass beads (0.5 mm diameter, 100 mL). CHCl 3 /MeOH (1:1, v/v, 4 C) (900 mL) was added and vortexed (2 3 30 s). HCl (1 M, 200 mL, 4 C) was added and vortexed (2 3 30 s). The samples were centrifuged (5,000 g, 2 min, 4 C) to complete phase separation. 500 mL of the organic phase was transferred to a clean tube and dried under Ar(g). The remaining organic residue was reconstituted in ACN/IPA/H 2 O (65:30:5, v/v/v) (100 mL) for LC-MS analysis.
Human Plasma Lipid Extraction
Human plasma (Innovative Research, (20 mL) was thawed on ice and vortexed. MeOH (4 C) (225 mL) was added and vortexed (30 s). Methyl tert-butyl ether (750 mL, 4 C) was added and vortexed (30 s). The samples were mixed using an orbital shaker (6 mins) to extract lipids. H 2 O (225 mL, 4 C) was added and vortexed (30 s) to induce phase separation. Samples were centrifuged (14,000 g, 2 min, 4 C) to complete phase separation. 200 mL of the organic phase was transferred to a clean vial and dried in a vacuum centrifuge (45 min). The organic residue was reconstituted in MeOH/Toluene (9:1, v/v) (100 mL) for LC-MS/MS analysis.
LC-MS/MS Acquisition
Sample analysis was performed on an Acquity CSH C18 column held at 50 C (2.1 x 100 mm x 1.7 mm particle size; Waters Corporation) using a Vanquish Binary Pump (400 mL/min; Thermo Scientific). Mobile phase A consisted of 10 mM ammonium acetate in ACN/H 2 O (70:30, v/v) containing 250 mL/L acetic acid. Mobile phase B consisted of 10 mM ammonium acetate in IPA/ACN (90:10, v/v) with the same additives. Initially, mobile phase B was held at 2% for 2 min and then increased to 30% over 3 min. Mobile phase B was then further increased to 85% over 14 min and then raised to 99% over 1 min and held for 7 min. The column was then re-equilibrated for 5 min before the next injection. Ten microliters of lipid extract were injected by a Vanquish autosampler (Thermo Scientific). The LC system was coupled to a Q Exactive HF mass spectrometer (Thermo Scientific) by a HESI II heated ESI source (Thermo Scientific). The MS was operated in positive and negative mode during sequential injections collecting both MS 1 and MS 2 spectra. For detailed MS acquisition parameters, reference Table S3 .
QUANTIFICATIONS AND STATISTICAL ANALYSIS LC-MS/MS Data Analysis
The resulting LC-MS data were processed using Compound Discoverer 2.0 (Thermo Scientific). For a detailed description of all data processing parameters used, reference Table S4 . Briefly, all MS 1 scans were extracted (Select Spectra node) and aligned (Align Retention Times node) across all LC-MS/MS experiments. Chromatographic features were subsequently detected from the aligned scans (Detect Unknown Compounds node) and grouped according to common m/z and elution profile (Group Unknown Compounds node). Each LC-MS/MS experiment was then re-searched to minimize feature groups which contained missing values (Fill Gaps node). Finally, feature groups which were present in the blank injection were removed (Mark Background Compounds node). To generate an unaligned dataset, MS 1 scans were extracted (Select Spectra node) and Chromatographic features were subsequently detected from the aligned scans (Detect Unknown Compounds node) using the same parameters as the aligned dataset. MS/MS spectra were converted to the MGF format using Proteowizard 3.0 (ProteoWizard Software Foundation v3.0) and searched against the LipiDex_HCD_Acetate, LipiDex_HCD_Hydroxy, and LipiDex_HCD_ULCFA libraries using Spectrum Searcher. In Peak Finder, lipid spectral matches were assigned to chromatographic features via precursor m/z and retention time. Lipid identifications were further filtered via MS/MS spectral purity, retention time, and chromatographic profile to remove artifacts and redundant identifications.
NIST MS/MS Dot Product Optimization Dataset MS/MS lipid reference standard spectra which were collected under similar MS/MS conditions as those used in the LC-MS/MS dataset were extracted from the NIST Tandem Mass Spectral Library. For the HCD dataset, 82 phospho-, glycero-, and sphingo-lipid MS/MS spectra which were fragmented using higher-energy collisional dissociation (HCD) and a collision energy between 40-50 eV were extracted. For the CID dataset, 89 phosho-, glycero-, and sphingo-lipid MS/MS spectra which were fragmented using ion trap collision induced dissociation were extracted. In Spectrum Searcher, the spectra were analyzed using the dot-product equation described above with varying mass and intensity weights (0.1 to 3.0) and the search parameters listed in Table S3 . Lipid identifications were deemed correct if they identified the correct fatty acid moieties or, if in the case of indistinguishable spectra (i.e. PC [M+H] + spectra), the correct sum identification.
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Lipid Data Analyzer 2 Comparison Dataset
To effectively compare the MS/MS identification performance of LipiDex against the recently published Lipid Data Analyzer 2 (Hartler et al., 2017) , a dataset comprising 7 LC-MS/MS analyses of a lipid reference standard mix was downloaded from the LDA 2 software homepage (http://genome.tugraz.at/lda2/data/ControlExperiment1/Exp1_QExactive.zip) and analyzed using both LDA 2 and LipiDex. Lipids were identified in LDA 2 using precursor mass matching parameters of 2 matching isotopes, the Q Exactive positive and negative mass lists from the Biological Experiment dataset (http://genome.tugraz.at/lda2/data/Biological/Bio_QExactive.zip), and the OrbiTrap_exactive_neg and OrbiTrap_exactive_MS/MS rule sets. In LipiDex, MS/MS files were searched against the Lipidex_Formic spectral library using a 0.02 Th MS1 search tolerance, 0.02 MS2 Th search tolerance, 1 max search results returned, and a 61.0 Th MS2 low mass cutoff. To directly compare MS/MS identification performance, the spectral identifications from both programs were matched to the LDA 2-generated feature list and compared at the sum composition and molecular composition level for all lipid class excluding the deuterium-labelled TG standards which are not present included in both programs' libraries For reference standard feature identifications, identifications between LipiDex and LDA 2 were matched if both programs returned the same molecular composition identification. For identification of all lipid features, identifications were matched if both programs returned identical sum lipid identifications. MS/MS signal-to-noise was calculated for each spectrum using the ratio of the most intense spectral peak to the median spectral peak intensity (Yang et al., 2014) .
In-Silico Co-Fragmentation Dataset Lipid co-fragmentation was simulated by mixing experimental isobaric lipid spectra in-silico across varying rations and analyzing the resulting spectra using the spectral deconvolution algorithm. MS/MS identifications were generated from LC-MS/MS data as above and only high-scoring and high-purity MS/MS (dot-produce>890, purity>98%, maximum intensity>1.0E 5 ) were retained for in-silico mixing. Isobaric spectra were then added together and their intensities modulated to mix spectra at various ratios (1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, and 5:1). The mixed spectra were then re-searched using Spectrum Searcher to generate spectral purity values. Major data processing features (green bars) of common LC-MS software packages including peak detection, result filtering, and lipid identification. Note that although care was taken to carefully classify each package, this table is not meant to be an exhaustive list of either all lipidomics software or all possible data processing routines. Color coded values for the median score, median score difference to next match, and correct identifications for the top-scoring spectral matches from 89 lipid reference standard spectra from the NIST Tandem Mass Spectral Library collected using resonant excitation ion trap CID and searched using various combinations of intensity and mass weighting factors. (B) Reference standard feature sum identification overlap (dark blue) between LipiDex (light blue) and LDA 2 (aqua blue) and number of unique reference standards identified at the molecular composition level by LipiDex (orange dots) out of 71 possible across varying minimum dot product thresholds. Note that MS/MS identification performance does not deteriorate until a very conservative dot-product threshold (>750) is used.
DATA AND SOFTWARE AVAILABILITY
(C) Feature sum identification overlap (dark blue) between LipiDex (light blue) and LDA 2 (aqua blue) for all detected features and the MS/MS signal-to-noise (S/N) ratio for the unique features identified by each package. Note the rule-based matching technique of LDA 2 identifies lipids from MS/MS spectra with lower S/N ratios than LipiDex due to noise peaks artificially reducing the dot-product score.
(D) Example spectra, returned identification, and S/N ratio for two unique features identified by LDA 2 which demonstrate appropriate lipid identification (upper panel) and spurious lipid detection (lower panel) at low S/N levels. Although rule-based matching often returns more lipid identifications from noisy spectra than the more conservative dot-product score, manual verification is needed to ensure these identifications are warranted The Scan Queue (SQ) is first populated with the spectral matching results and is rank-ordered by the dot-product score. MS/MS peaks corresponding to the most intense fatty acid-identifying fragment type are found and subtracted from the spectrum using the correction factor found in the Correction List (CL). Depending on the number of fatty acid moieties, a specific matched fragment (either the maximum or median intensity chain identifying fragment depending on the lipid) is added to the Intensity List (IL) and used to calculate the relative abundance of the species in the spectrum. This process is repeated until all candidate spectral matches are processed and a spectral purity value is calculated. (C) Indistinguishable spectra which contain no fatty acid-specific fragments identified with sum molecular composition.
(D) Lipids differentiated with MS/MS which contains fatty-acid specific fragment annotated with molecular lipid composition.
(E) Mixed lipid spectra which contain major co-fragmentation of isobaric species annotated with sum composition.
(F) Mixed lipid spectra which contain minor co-fragmentation of isobaric species annotated with molecular composition. LipiDex includes an imported library which was generated from the MS-Dial LipidBlast fork (Tsugawa et al., 2015) . The LipidBlast library was generated from diverse MS/MS setupsand is most performant when used with MS/MS spectra fragmented using collision-induced dissociation (CID). Detailed data collection and parameters for the experimental dataset presented in the manuscript. Note that, although optimized, the parameters represent a suitable starting point for lipid analysis for the QE HF and should be systematically optimized for users' specific LC-MS/MS setup. 
